ΝΟΣΗΜΑΤΑ
1. Breslow J.L., Zannis V.I., SanGiacomo T.R., Third J.L., Tracy T.: Glueck CJ.Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res. 1982 Nov; 23 (8) :1224-35.
2. Buyru N., Altinisik J., Gurel C.B.: Ulutin T.PCR-RFLP detection of PAI-2 variants in myocardial infarction. Clin Appl Thromb Hemost. 2003 Oct; 9(4):333-6.
3. Carlizza A.: Thrombophilia and pregnancy; Minerva Cardioangiol. 2006 Dec; 54 (6):799-801. http://www.ncbi.nlm.nih.gov/pubmed/17393610
4. Che D., Nicolau J., Bergounioux J., Perez T., Bitar D.: Bronchiolitis among infants under 1 year of age in France: epidemiology and factors associated with mortality; Arch Pediatr. 2012 Jul; 19(7):700-6. doi: 10.1016/ j.arcped.2012.04.015. http://www.ncbi.nlm.nih.gov/pubmed/22652519
5. David M.S. et al: Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project; Genet Med. 2011 Mar;13(3):230-54. http://www.ncbi.nlm.nih.gov/pubmed?term=Genet.%20Med.%2013%20(2011)%20230-254
6. Davis W.A., Brown S.G., Jacobs I.G., Bulsara M., Beilby J., Bruce D.G., Davis T.M.: Angiotensin-converting enzyme insertion/deletion polymorphism and severe hypoglycemia complicating type 2 diabetes: the Fremantle Diabetes Study. J Clin Endocrinol Metab. 2011 Apr;96 (4) :E696-700.
7. Gerhardt A., Goecke T.W., Beckmann M.W., Wagner K.J., Tutschek B., Willers R., Bender H.G., Scharf R.E., Zotz R.B.: The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost. 2005 Apr; 3(4):686-91.
8. Kanavakis E. et al: Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals; Clin Genet. 2003 May; 63(5):400-9. http://www.ncbi.nlm.nih.gov/pubmed/12752573
9. Kreidy R., Salameh P., Waked M.: Lower extremity venous thrombosis in patients younger than 50 years of age; Vasc Health Risk Manag. 2012; 8:161-7; e-pub 2012 Mar 13. http://www.ncbi.nlm.nih.gov/pubmed/22454560
10. Kokotas H., Grigoriadou M., Hatzaki A., Antoniadi T., Giannoulia-Karantana A., Petersen M.B.: Easy, rapid, and cost-effective methods for identifying carriers of recurrent GJB2 mutations causing nonsyndromic hearing impairment in the Greek population; Genet Test Mol Biomarkers; 2010 Apr; 14(2):189-92. http://www.ncbi.nlm.nih.gov/pubmed/20059378
11. Lambrinoudaki I. et al: The frequency of early, spontaneous miscarriage associated with the leu33pro polymorphism of Glycoprotein IIIa: a pilot study; Aust N Z J Obstet Gynaecol. 2010 Oct; 50(5):485-90. doi: 10.1111/j.1479-828X.2010.01196.x. http://www.ncbi.nlm.nih.gov/pubmed/21039385
12. Loukas Y.L. et al: Expanded newborn screening in Greece: 30 months of experience; J Inherit Metab Dis. 2010 Aug 19. [e-pub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/20721692
13. Marquardt Gregg: Enhanced interpretation of newborn screening results without analyte cutoff values; Genet Med. 2012 Jul; 14 (7):648-55. doi: 10.1038/gim.2012.2. http://www.ncbi.nlm.nih.gov/pubmed?term=Genet.%20Med.%2014%20(2012)%20648-655
14. Metcalfe, Sylvia A.: “Carrier screening in preconception consultation in primary care”; J Community Genet. 2012 July; 3(3): 193–203. Published online 2011 December 20. doi: 10.1007/s12687-011-0071-z. http://www.ncbi.nlm.nih.gov/pmc/?cmd=Retrieve&dopt=docsum&list_uids=3419291
15. Pastinen T., Perola M., Niini P., Terwilliger J., Salomaa V., Vartiainen E., Peltonen L.: Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet. 1998 Sep;7 (9):1453-62.
16. Rahimi Z., Hasanvand A., Felehgari V.: Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran. DNA Cell Biol. 2012 Apr;31(4):553-9.
17. Rigat Brigitte, Hubert Christine, Corvol Pierre and Soubrier Florent: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992 March 25; 20(6): 1433.
18. Rossaak J.I., Van Rij A.M., Jones G.T., Harris E.L.: Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. J Vasc Surg. 2000 May;31(5):1026-32.
19. Santoso S., Kunicki T.J., Kroll H., Haberbosch W., Gardemann A.: Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood. 1999 Apr 15;93(8):2449-53.
20. Sie P., Caron C., Azam J., Goudemand J., Grandjean H., Boneu B., Fournie A.: Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1 and 2 during normal pregnancy. Br J Haematol. 2003 Jun;121(6):897-903.
21. Snoeckx R.L. et al: GJB2 mutations and degree of hearing loss: a multicenter study; Am J Hum Genet. 2005 Dec; 77(6):945-57. e-pub 2005 Oct 19. http://www.ncbi.nlm.nih.gov/pubmed/16380907
22. Sugarman Elaine A. et al: Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72400 specimens; Eur J Hum Genet. 2012 January; 20(1): 27–32. doi: 10.1038/ ejhg.2011.134. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234503/
23. Thodi G. et al: Mutational analysis for biotinidase deficiency of a Greek patients’ cohort ascertained through expanded newborn screening ; J Hum Genet. 2011 Dec; 56(12):861-5. doi: 10.1038/jhg.2011.119. e-pub 2011 Oct 20. http://www.ncbi.nlm.nih.gov/pubmed/22011816
24. Thodi G. et al: Characterization of the molecular spectrum of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in a Greek newborns cohort: identification of a novel variant. ; Clin Biochem. 2012 Oct; 45(15):1167-72. doi: 10.1016/j.clinbiochem.2012.05.030. http://www.ncbi.nlm.nih.gov/pubmed/22683754
25. Tybjaerg-Hansen A., Humphries S.E.: Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis. 1992 Oct;96(2-3):91-107.
26. Undas A., Brummel K., Musial J., Mann K.G., Szczeklik A.: Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation. 2001 Nov 27;104(22):2666-72.
27. Varga E.A., Kujovich J.L.: Management of inherited thrombophilia: guide for genetics professionals; Clin Genet. 2012 Jan; 81(1):7-17. doi: 10.1111/j.1399-0004.2011.01746.x. e-pub 2011 Jul 25. http://onlinelibrary.wiley.com/doi/10.1111/j.1399-0004.2011.01746.x/pdf
28. Villani M. et al: Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias; J Thromb Haemost. 2012 Feb; 10(2):223-8. doi: 10.1111/j.1538-7836.2011.04583.x. http://www.ncbi.nlm.nih.gov/pubmed/22136658
29. Yenicesu G.I., Cetin M., Ozdemir O., Cetin A., Ozen F., Yenicesu C., Yildiz C., Kocak N.: A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss. Am J Reprod Immunol. 2010 Feb;63(2):126-36.
30. Yu ZY, Chen L.S., Zhang L.C., Zhou T.B.: Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton). 2012 Jul;17(5):480-7.